AI
ELV icon

Axecap Investments’s Elevance Health ELV Stock Holding History

Axecap Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$927K Hold
2,396
– – 0.51% 44
2026
Q1 		$701K Hold
2,396
– – 0.48% 43
2025
Q4 		$840K Sell
2,396
-29
-1% -$9.8K 0.52% 52
2025
Q3 		$784K Sell
2,425
-100
-4% -$31.1K 0.48% 63
2025
Q2 		$982K Sell
2,525
-75
-3% -$30.2K 0.64% 48
2025
Q1 		$1.13M Buy
+2,600
New +$1.04M 0.96% 35

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Axecap Investments's ELV Position: Q2 2026 in Review

Axecap Investments held its Elevance Health (ELV) position steady in Q2 2026 at 2,396 shares worth $927K. The position accounts for 0.51% of the portfolio, ranked #44.

Axecap Investments first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.13M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Axecap Investments held 2,396 shares of Elevance Health worth $927K as of Q2 2026.
  • Axecap Investments left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.51% of Axecap Investments's portfolio in Q2 2026, its #44 holding.
  • Axecap Investments first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • Axecap Investments's Elevance Health position peaked at $1.13M in Q1 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Axecap Investments's 13F filing for Q2 2026, filed 10 Aug 2026.